An octadecameric O-glucosyltransferase generates diversity in antibody epitopes on variant surface antigens in African trypanosomes

Immune evasion in many pathogens relies on sequence variation to generate antigenic diversity. African trypanosomes use an additional strategy where O-glucosylation of variant surface glycoproteins (VSGs) generates heterogeneous glycans that alter antibody epitope recognition, influencing infection outcome. However, the VSG O-glycosylation enzyme has remained unknown. Here, we identify ESAG3 as the glycosyltransferase required for generating these O-glycan-dependent epitopes. ESAG3 depletion in vivo abolishes O-glycosylation-specific monoclonal antibody recognition, while complementation restores binding. ESAG3 has strict UDP-glucose specificity, manganese dependence, and modifies serine/threonine residues within cysteine-flanked VSG peptides. Single-particle cryo-electron microscopy reveals that ESAG3 forms an unprecedented octadecameric architecture with C3 symmetry at 3.4 angstrom resolution, a novel quaternary organisation for a glycosyltransferase. Structure-guided mutagenesis demonstrates essential active-site residues for catalysis, while interface mutations disrupt octadecamer assembly and enhance substrate turnover, indicating that oligomeric architecture regulates catalytic output. This work establishes ESAG3 as a kinetoplastid-specific glucosyltransferase and reveals the molecular basis whereby VSG O-glycosylation generates epitope diversity alongside sequence-based antigenic variation. Significance statementAfrican trypanosomes evade host immunity by switching variant surface glycoproteins (VSGs) from a vast gene archive, generating extreme antigenic diversity through sequence polymorphism. O-glucosylation adds a second layer where heterogeneous O-linked sugars at the very top of surface-exposed VSG loops diversify the epitope space accessible to host antibodies. We identify ESAG3 as the O-glucosyltransferase responsible for this modification and reveal it forms an unprecedented 18-subunit architecture. Critically, ESAG3 is encoded within VSG expression sites, coupling O-glycosylation to monoallelic transcriptional control. When parasites switch expression sites, VSG sequence changes alongside co-transcribed O-glycosylation machinery, integrating genetic and chemical variation into a unified immune evasion strategy. This work provides the molecular and structural basis for O-glycan-mediated epitope control on the trypanosome surface.